Sign in
CompletedNo phase

Notched Noise Therapy for Suppression of Tinnitus

Key facts

Who runs it
VA Office of Research and Development
Where
Durham, United StatesSee the site
Trial code
Status
Completed
People taking part
108 people enrolled
Started
1 Mar 2023
Ended
31 May 2026
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Hearing Aid and Notched Noise Therapy
  • Hearing Aid and Broadband Noise
  • Hearing Aid
Record updated
14 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Candidates must meet the following inclusion criteria to qualify:
  • Veteran
  • no active middle-ear disease
  • at least one air conduction hearing threshold of 40 dB HL or worse in each ear between .25-8 kHz as measured at the first study visit
  • unilateral or bilateral constant tinnitus
  • index score on the Tinnitus Functional Index (TFI) of at least 25 (out of a maximum score of 100)
  • a score of 24 or higher on the Mini Mental State Exam (MMSE)
  • a tinnitus pitch match between 2-10 kHz (and achieve desired level of precision as described below in 3.3 Study Procedures, Tinnitus Psychoacoustic Assessment)
  • demonstrates understanding of the requirements of the study
  • motivated and capable of participating (including ability to communicate in English)

Who cannot take part

  • suspicion of secondary (somatic) tinnitus, Meniere's disease, or tinnitus potentially related to temporo-mandibular disorder or whiplash (any of which can be ruled out with an examination by an appropriate physician)
  • any mental, emotional, or health conditions that would preclude full study participation
  • The following exclusion criteria will be used:
  • two or more hearing thresholds exceeding 70 dB HL
  • significant conductive hearing loss-defined as an air-bone gap of 15 dB at more than two frequencies in one ear, or an air-bone gap greater than 15 dB at any one frequency

Where in United States

  • Durham VA Medical Center, Durham, NCDurham, United States

About the trial

What the trial wants to find out

Tinnitus ("ringing in the ears") has long been a problem for Veterans. The problem continues to escalate due to high levels of noise in the military, and because tinnitus often is associated with traumatic brain injury and post-traumatic stress disorder. In spite of limited research support, sound-based (acoustic) therapies are most often used for tinnitus intervention, and increasing numbers of commercial devices are becoming available that offer various acoustic-stimulus protocols. The proposed study will provide evidence from a randomized controlled trial comparing effects of acoustic-stimulus methods that are purported to suppress tinnitus and/or reduce its functional effects. The study will focus on methods with the strongest scientific rationale, i.e., noise that is notched around the predominant tinnitus-frequency region. Special ear-level devices will deliver these acoustic-therapy protocols that are purported to modify tinnitus-related neural activity. The study will follow a study recently completed by the applicant that provides preliminary evidence supporting this method.

The 3 groups in the trial

  • Amplification + Notched Noise TherapyTreatment being tested

    Following the baseline assessment, participants will be randomly assigned to one of the study groups. This treatment group will include a Notched Noise Therapy, a 1-10 kHz noise "notched" within a 1-octave range centered around the psychoacoustic tinnitus pitch match measured. Randomized participants will wear their hearing aids with this loaded software for 8 weeks. They will be seen at a baseline, 4 week, and 8 week visits for outcome measures and any adjustments in hearing aid comfort.

    Treatment: Hearing Aid and Notched Noise Therapy

  • Amplification + Broadband NoiseExisting treatment, for comparison

    Following the baseline assessment, participants will be randomly assigned to one of the study groups. A popular and commonly used sound therapy treatment, this treatment group will listen to a broadband noise, or "white noise," that is housed on the manufacturer's hearing aid tinnitus program. They will be seen at a baseline, 4 week, and 8 week visits for outcome measures and any adjustments in hearing aid comfort.

    Treatment: Hearing Aid and Broadband Noise

  • Amplification OnlyPlacebo, for comparison

    Following the baseline assessment, participants will be randomly assigned to one of the study groups. Hearing aids are ear-level, self-contained, FDA-approved hearing device. Hearing aids help individuals with hearing loss and provide safe amplification/gain to frequencies that have loss.

    Treatment: Hearing Aid

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Notched Noise Therapy for Suppression of Tinnitus: A Randomized Controlled Trial
Record updated
14 September 2026